POMPANO BEACH, Fla., April 8, 2024 /PRNewswire/ -- International Medical Industries, Inc. (IMI) is thrilled to announce an innovative partnership with Grifols that promises to enhance medication safety through cutting-edge technology. IMI, the industry leader in secure drug delivery devices, is joining forces with Kiro Grifols, dedicated to the state-of-the-art automated pharmacy compounding device (PCD), KIRO Fill. This strategic alliance aims to ensure the utmost security and integrity of compounded medications by combining the KIRO Fill with IMI's industry-leading Tamper Evident Caps.
Grifols™ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections Arboviruses are a growing emerging threat, with changes in...
Shares in Spanish drugmaker Grifols tumble on Fitch, S&P downgrades
Grifols says due diligence done, Shanghai RAAS stake sale to go ahead
Spanish supervisor analysing new information from Grifols
Grifols appoints new CEO Nacho Abia to the board
Grifols preps blood clot treatment approval push after ph. 3 win
Spain's Grifols hires new CEO weeks after damaging short-seller report
Grifols files lawsuit against hedge fund for making `false and misleading statements`
Spain's Grifols sues Gotham City fund, JV over damaging report